Refine by
Diabetes Management Articles & Analysis
36 news found
Bremen, Germany – May 4, 2026 — Kerecis, the company pioneering the use of sustainably sourced intact fish skin in cellular therapy and tissue regeneration, will play a prominent scientific and educational role at EWMA-DEWU 2026 Conference, taking place May 6–8 at the Messe & Congress Centrum Bremen in Bremen, Germany.This year EWMA, The European Wound Management Association ...
ByKerecis
Ace Therapeutics launches its cutting-edge in vivo models of diabetes mellitus. These models—chemically induced, genetically engineered, or diet-induced—have the potential to advance diabetes research by giving scientists the means to support the identification and development of novel treatment approaches. ...
Some of the anti-tumor APIs supplied by Protheragen-ING are: enzalutamide, olaparib, idelalisib, neratinib maleate, ixazomib citrate, bendamustine hydrochloride monohydrate, ponatinib HCL, dasatinib, lenalidomide, afatinib dimaleate, etc. Dedicated Solutions for Diabetes Management For diabetes, Protheragen-ING’s hypoglycemic APIs are the ...
This novel glucagon-like peptide-1 (GLP-1) receptor agonist has generated significant excitement within the pharmaceutical and life sciences industries due to its remarkable efficacy in managing type 2 diabetes. Semaglutide represents a paradigm shift in the treatment of type 2 diabetes, as it targets the root causes of the disease rather than ...
The prevalence of CKD due to T1D increased by 58.2% from 1990 to 2007 and by 21.7% from 2007 to 2017. “Apart from diabetes and hypertension management, there are currently very limited treatment options to slow kidney disease progression in people with chronic kidney disease and type 1 diabetes,” said Janet McGill, Professor of ...
ByBayer AG
As a biotech startup, this patent validates Alertgy’s state-of-the-art technology as it continues to be improved, with the ultimate goal of transforming the world of diabetes management. How Alertgy is Reinventing the Diabetic Industry Alertgy’s continuous glucose monitor does not require any ...
ByAlertgy
Therefore, we are responding to the urgent humanitarian need for diabetes health medical supplies resulting from the invasion of Ukraine. ...
ByLifeScan
“Patients with chronic kidney disease and type 2 diabetes are three times more likely to die from a cardiovascular event than those with type 2 diabetes alone. ...
ByBayer AG
An estimated 415 million people are living with diabetes in the world. Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye ...
Despite their motivation, patients acknowledged that they continue to face challenges in managing their diabetes and said they look to their healthcare providers to help them make necessary adjustments to better manage their diabetes and to support them along their journey. ...
ByLifeScan
Seventy percent of medical decisions depend on lab test results, so making this important service convenient and accessible is key to improving health care quality and managing long-term health costs. Take diabetes, the most expensive chronic condition in the U.S. ...
“These results are very important, as they show clinically meaningful effects of intralymphatic Diamyd on CGM outcomes that are of great importance to patients as they reflect the day-to-day challenges of managing their diabetes despite current best standard of care,” says Johnny Ludvigsson, Professor at Linköping University, Coordinating ...
Schmid brings extensive operations and business development leadership experience in diabetes and drug delivery. As Vice President of Operations and Business Development at Insulet Corporation, he was instrumental in the development, manufacturing, and commercialization of wearable smart drug delivery pumps such as the Omnipod Diabetes Management ...
Longenesis announced today the preliminary results from its study on Type 1 Diabetes care in partnership with Medtronic. In less than three months, more than 85 patients participated in the research study, providing qualitative and quantitative data on the quality of life for Type 1 diabetics using insulin pumps compared to daily insulin injections. ...
(Regenstrief) today announced the development of an AI method to improve care for patients with type 2 diabetes mellitus who need complex treatment. One in 10 adults worldwide have been diagnosed with type 2 diabetes, but a smaller number require multiple medications to control blood glucose levels and avoid serious complications, such as loss of vision and ...
Recently, the Dave and Amber Show included special guest veteran sportscaster Mike Golic, talking about his own type two diabetes diagnosis and journey, and his new national Talking Type You campaign designed to encourage open conversation among people with diabetes about the realities of managing the condition and empower them to create a ...
ByLifeScan
“We repeatedly hear from our patients with diabetes that what they desire is a long-lasting sensor that is also highly accurate,” said Satish Garg, M.D., Professor of Medicine and Director of the Adult Diabetes Program at the Barbara Davis Center of the University of Colorado, and the Principal Investigator of the PROMISE Study1, which formed the ...
” Digital Diagnostics created IDx-DR, the autonomous AI diagnostic system for the detection of diabetic retinopathy (DR) and diabetic macular edema (DME) at the point-of-care. Only 15% of people with diabetes receive the recommended annual diabetic eye exam, and this lack of access is linked to widespread blindness, ...
I look forward to working with the Modular Medical team in addressing areas of improving diabetes care by tackling the most significant barriers: access and affordability, and making it easier for clinicians, caregivers and individuals to manage diabetes care," said O'Connor Vos. ...
Additionally, a high-quality paper published on April 19, 2021 in the journal Diabetic Medicine, entitled Topical oxygen therapy for diabetes-related foot ulcers: A systematic review and meta-analysis (https://onlinelibrary.wiley.com/doi/10.1111/dme.14585), from the team headed by Professor Golledge at the independent Queensland Research Centre for Peripheral ...